The Asia-Pacific sodium reduction ingredient market is expected to register a CAGR of 10.0%, during the forecast period from 2018 to 2023. While demand for mineral salts, as SRI is the largest in Asia-Pacific, is cornering over 50% of the share estimated in 2016, the fastest growth is expected from yeast extracts.
Excessive intake of sodium leads to a number of adverse health effects, hypertension being foremost among them. Alleviating these conditions to some extent has been possible through the use of SRI, such as mineral salts, amino acids, and yeast extracts. Versatility in its application has provided the requisite impetus to these health-promoting products.
Some of the major factors driving demand for SRI include the greater emphasis on health nutrition, the growing knowledge with regard to the detrimental effects of excessive intake of salt, improvement in taste, and increased demand for processed foods.
The SRI market is segmented by type into amino acids & glutamates, mineral salts, yeast extracts, and others. By application, it is segmented into bakery & confectionery, condiments, seasonings & sauces, dairy & frozen foods, meat & meat products, and other snacks. By application, largest consumption of SRI has been observed in meats and meat products, followed by snacks, with these two areas also expected to grow fast.
The share of Asia-Pacific in the global market for SRI is relatively small but the demand for these products in the region is likely to witness a rapid growth as countries, such as China and India, with a large population of hypertensive individuals that have been advised to either cut down on or completely eliminate their sodium intake would be instrumental in propelling growth for SRI. China is the largest, and also the fastest growing market for SRI in Asia-Pacific.
Major Players: ADM, Angel Yeast Co. Ltd., Biospringer, Bunge Ltd, Cargill Inc, Danisco A/S, Kerry Group, Novozymes A/S, Purac Biochem BV, Royal DSM NV, Tate & Lyle Plc, among others.
Looking to Customize Report?